Pitolisant: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pitolisant. Educational only — not medical advice.
Labeled uses
WAKIX is indicated for the: treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy. treatment of excessive daytime sleepiness (EDS) in pediatric patients 6 years of age and older with narcolepsy.
Source: FDA labeling via NIH DailyMed (set 8daa5562…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.